Cingulate (CING) Capital Leases (2021 - 2023)
Cingulate's (CING) quarterly Capital Leases came in at $4436.0 in Q4 2023, down 79.35% YoY from $21487.0 in Q4 2022, and down 49.55% on a QoQ basis from $8792.0 in Q3 2023.
Cingulate (CING) Capital Leases (2021 - 2023) Analysis & Trends
Cingulate (CING) has 3 years of Capital Leases data on file, last reported at $4436.0 in Q4 2023.
- Quarterly Capital Leases fell 79.35% year-over-year to $4436.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $4436.0 (down 79.35% YoY) and the FY2023 annual result came in at $4436.0, down 79.35% from the prior year.
- Capital Leases fell to $4436.0 in Q4 2023, from $8792.0 in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $37534.0 in Q4 2021 to a low of $4436.0 in Q4 2023.
- A 3-year average of $21347.7 and a median of $21487.0 in 2022 frame the typical range for Capital Leases.
- Annual changes were most pronounced in 2022 — Capital Leases tumbled 42.75% — and 2023, when it plunged 79.35%.
- Tracing CING's Capital Leases over 3 years: stood at $37534.0 in 2021, then plunged by 42.75% to $21487.0 in 2022, then sank by 79.35% to $4436.0 in 2023.
- The last three Capital Leases figures came in at $4436.0 (Q4 2023), $8792.0 (Q3 2023), and $13723.0 (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cingulate | 72.85 Mn | 72.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 4,436.00 |
| Sep 30, 2023 | 8,792.00 |
| Jun 30, 2023 | 13,723.00 |
| Mar 31, 2023 | 17,320.00 |
| Dec 31, 2022 | 21,487.00 |
| Sep 30, 2022 | 25,591.00 |
| Jun 30, 2022 | 29,633.00 |
| Mar 31, 2022 | 33,613.00 |
| Dec 31, 2021 | 37,534.00 |